Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma

A. Sahal, K. James, V. Mitchell, J. Das, A. Mansur (Birmingham, United Kingdom)

Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Session: Biomarkers of asthma and clinical immunology
Session type: Thematic Poster Session
Number: 1032
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sahal, K. James, V. Mitchell, J. Das, A. Mansur (Birmingham, United Kingdom). Correlation of fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils (PBE) in refractory asthma. Eur Respir J 2014; 44: Suppl. 58, 1032

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma
Source: Annual Congress 2013 –Asthma
Year: 2013


Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014

Relationships between exhaled nitric oxide and atopic profiles (mono-sensitization/poly-sensitization) in asthmatic patients
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013


Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016

Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: the Copenhagen General Population Study
Source: Eur Respir J, 52 (2) 1800616; 10.1183/13993003.00616-2018
Year: 2018



LATE-BREAKING ABSTRACT: Relationships between exhaled nitric oxide and lung function profiles in severe asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Positive relationship between offline exhaled nitric oxide and lung clearance index in pre-school wheezers
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014

Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013

Relation of asthma control and exhaled nitric oxide in patients with bronchial hyperresponsiveness to methacholine
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016

Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Weak association between exhaled nitric oxide and bronchial responsiveness in asthmatic patients
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

Additive contribution of exhaled nitric oxide and sputum eosinophils to airway responsiveness
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA)
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015


Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Effect of environmental pollution on the control of bronchial asthma and fractional exhaled nitric oxide (FeNO)
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013


Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014